Skip to content

Compounds · Metabolic & weight · Metabolic regulation and exercise enhancement

MOTS-c

On NovaEvumFull protocol

Mitochondrial-derived peptide MOTS-c, MOTS-c peptide, Mitochondrial ORF of the 12S rRNA type-c

A mitochondria-derived peptide that helps regulate metabolism, partly by moving to the nucleus to influence gene expression through AMPK. Preclinical work from 2020–2025 suggests possible benefit in gestational diabetes, ovarian cancer, hepatitis B, septic heart injury, and lung reperfusion injury, but it has not reached clinical use.

5 mg 2–3× weekly, or 1 mg daily

Research score 60/100. Reference only, not a prescription.

  • Metabolic Enhancement
  • Muscle Growth
  • Anti-aging
  • Energy Boost
  • Exercise Enhancement
  • Insulin Regulation
US status
Research Chemical
Approval
Research Chemical Only
Evidence
Mitochondrial-derived peptide (MDP). Regulates metabolic homeostasis and exercise mimetic effects. Investigational for obesity and longevity.
Research score
60 / 100
Indication
Research Only - No Medical Indication
Origin
USA
Source category
Muscles & Joints
Status group
Research chemical

Mechanism

Activates AMPK signaling and, under metabolic stress, enters the nucleus to affect metabolic genes; improves insulin sensitivity and glucose uptake in muscle and boosts mitochondrial fatty-acid oxidation.

Safety file

Human safety is unestablished; theoretical risks include low blood sugar and mitochondrial overactivation, with injection-site reactions reported; banned by WADA at all times.

  • Injection site reactions
  • Temporary fatigue
  • Mild headache

Reconstitution

Concentration by vial size and water volume
Vial1 mL water2 mL water4 mL water
10 mg10 mg/mL5 mg/mL2.5 mg/mL
40 mg40 mg/mL20 mg/mL10 mg/mL

The 10 mg vial at 2 mL gives 5 mg/mL: a 1 mg dose is 0.2 mL (20 units) and a 5 mg dose fills a 1 mL syringe (100 units), so the 10 mg vial suits the 1 mg daily protocol. For 5 mg two or three times weekly, the 40 mg vial is easier: at 4 mL it gives 10 mg/mL, so 5 mg is a 0.5 mL draw (50 units).

  1. Use bacteriostatic water as the diluent.
  2. Add the water slowly, letting it run down the inside wall of the vial rather than onto the powder.
  3. Swirl gently to mix, then leave it to dissolve. Do not shake.
  4. Give it a few minutes. The finished solution should be clear and colourless.

Full mixing method

Protocol

Route: Subcutaneous

Standard protocol (subcutaneous)

  • 5 mg per dose, 2 to 3 times per week (for example Monday, Wednesday, Friday) is the common range
  • Beginners often start at 5 mg twice weekly and titrate up
  • A lower daily option is 1 mg per day
  • On the 10 mg vial at 2 mL (5 mg/mL), 1 mg is a 0.2 mL draw (20 units) and a 5 mg dose fills a full 1 mL syringe (100 units)
  • On the 40 mg vial at 4 mL (10 mg/mL), 5 mg is a tidier 0.5 mL draw (50 units)

Timing

  • Inject fasted in the morning, ideally 30 to 60 minutes before fasted cardio or training
  • It mimics the metabolic signal the body produces during fasting, so an empty stomach lines up with how it works
  • On rest days, dose in the morning all the same

Duration and stacking

  • Run 4 to 8 week blocks, then a break of similar length
  • Commonly stacked with NAD+ and 5-Amino-1MQ as a metabolic combination, hitting mitochondrial function and fat oxidation from different angles
  • Effects are cumulative, so judge it over weeks rather than per dose

Dosing detail

  • Common dosing is 5 mg, 2 to 3 times per week. Beginners start at 5 mg twice weekly. A lower daily option is 1 mg per day.
  • Inject fasted in the morning, often before cardio or training. Subcutaneous, rotate sites.
  • A mitochondrial-derived peptide that activates AMPK, studied for fat oxidation, insulin sensitivity and endurance.

Duration

  • Run 4 to 8 week blocks, then a break of similar length. Effects build over the cycle rather than from any single dose.

Notes

  • Human data are limited, so its effects on other hormones are not established.
  • The main reports are mild fatigue or injection-site reactions at higher doses. Human safety data are limited.
  • More is not better here: the lower signalling-style doses work fine. Inject subcutaneously and rotate sites.

Storage and handling

  • Keep the powdered (lyophilized) vial in a cool, dark place. Refrigerate it for longer-term storage before mixing.
  • Once reconstituted and refrigerated at 2–8 °C away from light, use the vial within 28 days.
  • Do not freeze a reconstituted vial, and keep it away from heat and sunlight.
  • If the solution turns cloudy, develops floating particles, or shows any other sign of degradation, stop using that vial.

Storage rules and when to discard

NovaEvum vial

Worksheet

2 mL bacteriostatic water yields 5 mg/mL. A 5 mg amount is 100 units (1 mL), half the vial. A 1 mg daily amount is 20 units.

Catalog fill
10 mg
Typical water
2 mL
Route
Subcutaneous
Cycle
4–8 weeks, then a break of similar length.
StepAmountFrequencyNotes
Common research amount5 mg2–3× weekly100 units at 5 mg/mL
Lower daily option1 mgOnce daily20 units at 5 mg/mL
  • Filed here under cellular health, not GLP-1. It is not an incretin analog.
  • Bacteriostatic water: 20–25 °C. Do not refrigerate the diluent.
  • Amounts on this sheet are reconstitution math for the vial, not a recommendation.